Healthy view on Biotech. Morningstar.com-Mar. 8, 2018
Not everyone will want to buy individual stocks, though. As well as some of these companies have done, there have also been numerous companies, especially in the small- and mid-cap areas, that have gone belly up after their drugs either couldn't get FDA approval or failed to move beyond their initial testing phases.
Sky